Nuvaira kündigt Vortrag zur Bedeutung der zielgerichteten Lungendenervierung bei der Behandlung von COPD auf dem Internationalen Kongress der ERS an
18. September 2018 02:00 ET
|
Nuvaira
PARIS, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Nuvaira, ein Unternehmen, das medizinische Geräte zur Behandlung von obstruktiven Lungenkrankheiten entwickelt, hat heute die Annahme eines klinischen...
Nuvaira annonce un exposé oral lors du congrès international de l’ERS pour discuter de l’importance de la dénervation ciblée du poumon afin de traiter la BPCO
18. September 2018 02:00 ET
|
Nuvaira
PARIS, 18 sept. 2018 (GLOBE NEWSWIRE) -- Nuvaira, un développeur de dispositifs médicaux pour traiter les maladies pulmonaires obstructives, a annoncé aujourd’hui l’acceptation par la European...
Nuvaira Announces Oral Presentation at ERS International Congress Discussing Significance of Targeted Lung Denervation to Treat COPD
18. September 2018 02:00 ET
|
Nuvaira, Inc.
PARIS, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Nuvaira, a developer of medical devices to treat obstructive lung diseases, announced the acceptance of a clinical abstract by the European Respiratory...
Nuvaira Announces 1st Patient Treated in RELIEF-1 Study Evaluating New Approach for Asthma Treatment
27. März 2018 08:00 ET
|
Nuvaira, Inc.
MINNEAPOLIS, March 27, 2018 (GLOBE NEWSWIRE) -- Nuvaira, a developer of medical devices to treat obstructive lung diseases, today announced treatment of the first patient in the RELIEF-1 Clinical...
Nuvaira Announces Four Clinical Abstracts Accepted for Presentation at ERS International Congress
07. September 2017 08:00 ET
|
Nuvaira, Inc.
MILAN, Italy, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Nuvaira, a developer of medical devices to treat obstructive lung diseases, today announced that four scientific abstracts featuring the Nuvaira™...
Nuvaira Announces Enrollment Completion in First Sham-Controlled Clinical Trial of Targeted Lung Denervation for COPD
27. Juni 2017 09:00 ET
|
Nuvaira, Inc.
MINNEAPOLIS, June 27, 2017 (GLOBE NEWSWIRE) -- Nuvaira (formerly known as Holaira), a developer of medical devices to treat obstructive lung diseases, today announced completion of patient...
Holaira Announces Company Name Change to Nuvaira
20. Juni 2017 09:00 ET
|
Nuvaira, Inc.
MINNEAPOLIS, June 20, 2017 (GLOBE NEWSWIRE) -- Holaira, a developer of medical devices to treat obstructive lung diseases, today announced that it has changed its name to Nuvaira, effective...